• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用滑动结合盒对接方法发现结合途径:奥司他韦与禽流感 H5N1 神经氨酸酶结合途径的应用。

Discover binding pathways using the sliding binding-box docking approach: application to binding pathways of oseltamivir to avian influenza H5N1 neuraminidase.

机构信息

Institute for Computational Science and Technology, Ho Chi Minh City, Vietnam.

出版信息

J Comput Aided Mol Des. 2013 Aug;27(8):689-95. doi: 10.1007/s10822-013-9675-1. Epub 2013 Aug 24.

DOI:10.1007/s10822-013-9675-1
PMID:23979194
Abstract

Drug binding and unbinding are transient processes which are hardly observed by experiment and difficult to analyze by computational techniques. In this paper, we employed a cost-effective method called "pathway docking" in which molecular docking was used to screen ligand-receptor binding free energy surface to reveal possible paths of ligand approaching protein binding pocket. A case study was applied on oseltamivir, the key drug against influenza a virus. The equilibrium pathways identified by this method are found to be similar to those identified in prior studies using highly expensive computational approaches.

摘要

药物结合和解离是瞬态过程,很难通过实验观察,也很难通过计算技术进行分析。在本文中,我们采用了一种经济有效的方法,称为“途径对接”,其中分子对接用于筛选配体-受体结合自由能表面,以揭示配体接近蛋白质结合口袋的可能途径。我们对奥司他韦(治疗甲型流感病毒的关键药物)进行了案例研究。通过这种方法确定的平衡途径与使用昂贵的计算方法在先前研究中确定的途径相似。

相似文献

1
Discover binding pathways using the sliding binding-box docking approach: application to binding pathways of oseltamivir to avian influenza H5N1 neuraminidase.利用滑动结合盒对接方法发现结合途径:奥司他韦与禽流感 H5N1 神经氨酸酶结合途径的应用。
J Comput Aided Mol Des. 2013 Aug;27(8):689-95. doi: 10.1007/s10822-013-9675-1. Epub 2013 Aug 24.
2
Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.I117V 取代介导的神经氨酸酶亚型 H5N1 禽流感 A 病毒奥司他韦耐药的分子机制。
J Infect Dis. 2013 Jan 1;207(1):89-97. doi: 10.1093/infdis/jis633. Epub 2012 Oct 10.
3
Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.发现 N-取代奥司他韦衍生物作为有效的和选择性的 H5N1 流感神经氨酸酶抑制剂。
J Med Chem. 2014 Oct 23;57(20):8445-58. doi: 10.1021/jm500892k. Epub 2014 Oct 8.
4
Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.利用多维计算分析理解奥司他韦对甲型H1N1和H5N1流感神经氨酸酶突变的交叉耐药性。
Drug Des Devel Ther. 2015 Jul 31;9:4137-54. doi: 10.2147/DDDT.S81934. eCollection 2015.
5
Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.基于晶体神经氨酸酶结构修饰奥司他韦的类似物抑制剂用于治疗耐药H5N1病毒。
Biochem Biophys Res Commun. 2007 Oct 19;362(2):525-31. doi: 10.1016/j.bbrc.2007.08.025. Epub 2007 Aug 13.
6
A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.通过针对神经氨酸酶进行计算筛选确定的一种新型禽流感H5N1病毒小分子抑制剂。
J Med Chem. 2009 May 14;52(9):2667-72. doi: 10.1021/jm800455g.
7
Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.甲型禽流感病毒H5N1亚型神经氨酸酶与奥司他韦、扎那米韦、帕拉米韦及其膦酸酯类似物复合物的动态行为
J Chem Inf Model. 2009 Oct;49(10):2323-32. doi: 10.1021/ci900277r.
8
Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".关于《再探甲型H5N1流感病毒神经氨酸酶(NA)对奥司他韦(OTV)耐药性的分子机制》的评论
Biophys Chem. 2009 Apr;141(1):131-2; author reply 133. doi: 10.1016/j.bpc.2009.01.009. Epub 2009 Feb 2.
9
Drugs against avian influenza a virus: design of novel sulfonate inhibitors of neuraminidase N1.抗甲型禽流感病毒药物:新型神经氨酸酶N1磺酸盐抑制剂的设计
Curr Pharm Des. 2014;20(21):3478-87. doi: 10.2174/13816128113199990629.
10
Assessing the susceptibility of highly pathogenic avian influenza H5N1 viruses to oseltamivir using embryonated chicken eggs.用鸡胚评估高致病性禽流感 H5N1 病毒对奥司他韦的敏感性。
Indian J Med Res. 2019 Nov;150(5):486-491. doi: 10.4103/ijmr.IJMR_845_18.

引用本文的文献

1
Indole-core inhibitors of influenza a neuraminidase: iterative medicinal chemistry and molecular modeling.流感 A 神经氨酸酶吲哚核心抑制剂:迭代药物化学和分子建模。
Eur J Med Chem. 2024 Nov 5;277:116768. doi: 10.1016/j.ejmech.2024.116768. Epub 2024 Aug 15.
2
Bioinformatic analysis of subfamily-specific regions in 3D-structures of homologs to study functional diversity and conformational plasticity in protein superfamilies.对同源物三维结构中亚家族特异性区域进行生物信息学分析,以研究蛋白质超家族中的功能多样性和构象可塑性。
Comput Struct Biotechnol J. 2021 Feb 23;19:1302-1311. doi: 10.1016/j.csbj.2021.02.005. eCollection 2021.
3

本文引用的文献

1
What has virtual screening ever done for drug discovery?虚拟筛选在药物发现中发挥了什么作用?
Expert Opin Drug Discov. 2008 Aug;3(8):841-51. doi: 10.1517/17460441.3.8.841.
2
The future of virtual compound screening.虚拟化合物筛选的未来。
Chem Biol Drug Des. 2013 Jan;81(1):33-40. doi: 10.1111/cbdd.12054.
3
Current trends in virtual high throughput screening using ligand-based and structure-based methods.使用基于配体和基于结构的方法进行虚拟高通量筛选的当前趋势。
Plasticity of the 340-Loop in Influenza Neuraminidase Offers New Insight for Antiviral Drug Development.
流感神经氨酸酶 340 环的可塑性为抗流感病毒药物研发提供了新的思路。
Int J Mol Sci. 2020 Aug 6;21(16):5655. doi: 10.3390/ijms21165655.
4
Thiamine and selected thiamine antivitamins - biological activity and methods of synthesis.硫胺素和选定的硫胺素抗维生素 - 生物活性和合成方法。
Biosci Rep. 2018 Jan 10;38(1). doi: 10.1042/BSR20171148. Print 2018 Feb 28.
Comb Chem High Throughput Screen. 2011 Dec;14(10):872-88. doi: 10.2174/138620711797537120.
4
Study of Tamiflu sensitivity to variants of A/H5N1 virus using different force fields.使用不同力场研究达菲对 A/H5N1 病毒变异株的敏感性。
J Chem Inf Model. 2011 Sep 26;51(9):2266-76. doi: 10.1021/ci2000743. Epub 2011 Aug 23.
5
Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations.通过分子动力学模拟完整重建酶抑制剂结合过程。
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10184-9. doi: 10.1073/pnas.1103547108. Epub 2011 Jun 6.
6
Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases.分子动力学模拟表明,静电漏斗指导达菲与流感 N1 神经氨酸酶的结合。
PLoS Comput Biol. 2010 Sep 23;6(9):e1000939. doi: 10.1371/journal.pcbi.1000939.
7
A Comparison of Three Perturbation Molecular Dynamics Methods for Modeling Conformational Transitions.用于模拟构象转变的三种微扰分子动力学方法的比较
J Chem Theory Comput. 2009 Apr 9;5(5):1301-1314. doi: 10.1021/ct9000153.
8
Role of secondary sialic acid binding sites in influenza N1 neuraminidase.流感 N1 神经氨酸酶中次级唾液酸结合位点的作用。
J Am Chem Soc. 2010 Mar 10;132(9):2883-5. doi: 10.1021/ja9073672.
9
Top-hits for H1N1pdm Identified by Virtual Screening Using Ensemble-based Docking.通过基于集成对接的虚拟筛选确定的甲型H1N1流感大流行病毒优势毒株。
PLoS Curr. 2009 Sep 2;3:RRN1030. doi: 10.1371/currents.RRN1030.
10
Infiltration of water molecules into the oseltamivir-binding site of H274Y neuraminidase mutant causes resistance to oseltamivir.水分子渗透进入 H274Y 神经氨酸酶突变体的奥司他韦结合位点导致对奥司他韦的耐药性。
J Chem Inf Model. 2009 Dec;49(12):2735-41. doi: 10.1021/ci900348n.